Daniel Hassan

473 total citations
9 papers, 343 citations indexed

About

Daniel Hassan is a scholar working on Molecular Biology, Pharmaceutical Science and Microbiology. According to data from OpenAlex, Daniel Hassan has authored 9 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pharmaceutical Science and 3 papers in Microbiology. Recurrent topics in Daniel Hassan's work include Lipid Membrane Structure and Behavior (3 papers), Advanced Drug Delivery Systems (3 papers) and RNA Interference and Gene Delivery (2 papers). Daniel Hassan is often cited by papers focused on Lipid Membrane Structure and Behavior (3 papers), Advanced Drug Delivery Systems (3 papers) and RNA Interference and Gene Delivery (2 papers). Daniel Hassan collaborates with scholars based in South Africa, United States and Kenya. Daniel Hassan's co-authors include Thirumala Govender, Calvin A. Omolo, Chunderika Mocktar, Nagashekhara Molugulu, Sima Singh, Rahul Shukla, Prashant Kesharwani, Hibah M. Aldawsari, Victoria Oluwaseun Fasiku and Nikhil Agrawal and has published in prestigious journals such as International Journal of Pharmaceutics, International Journal of Biological Macromolecules and Drug Discovery Today.

In The Last Decade

Daniel Hassan

8 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Hassan South Africa 8 125 74 70 69 67 9 343
Eupa Ray India 14 130 1.0× 137 1.9× 159 2.3× 40 0.6× 103 1.5× 20 470
Leonardo Lima Fuscaldi Brazil 12 94 0.8× 39 0.5× 78 1.1× 83 1.2× 113 1.7× 34 509
Eshant Bhatia India 9 134 1.1× 70 0.9× 42 0.6× 23 0.3× 37 0.6× 13 324
Jitendra Amrutiya India 9 185 1.5× 70 0.9× 172 2.5× 68 1.0× 108 1.6× 10 426
Giovanna Cassone Salata Brazil 12 126 1.0× 50 0.7× 114 1.6× 35 0.5× 170 2.5× 21 397
Parikshit Banerjee China 12 139 1.1× 149 2.0× 142 2.0× 20 0.3× 87 1.3× 16 494
Basmah N. Aldosari Saudi Arabia 12 236 1.9× 71 1.0× 95 1.4× 26 0.4× 123 1.8× 42 559
Devina Verma India 11 101 0.8× 56 0.8× 104 1.5× 28 0.4× 213 3.2× 15 418
Shivam Sharma India 6 127 1.0× 64 0.9× 32 0.5× 18 0.3× 33 0.5× 18 296
Usri H. Ibrahim South Africa 10 96 0.8× 83 1.1× 78 1.1× 10 0.1× 58 0.9× 21 302

Countries citing papers authored by Daniel Hassan

Since Specialization
Citations

This map shows the geographic impact of Daniel Hassan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Hassan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Hassan more than expected).

Fields of papers citing papers by Daniel Hassan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Hassan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Hassan. The network helps show where Daniel Hassan may publish in the future.

Co-authorship network of co-authors of Daniel Hassan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Hassan. A scholar is included among the top collaborators of Daniel Hassan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Hassan. Daniel Hassan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Hassan, Daniel, et al.. (2022). Novel vancomycin free base – Sterosomes for combating diseases caused by Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus infections (S. Aureus and MRSA). Journal of Drug Delivery Science and Technology. 79. 104089–104089. 12 indexed citations
3.
Omolo, Calvin A., Daniel Hassan, Nikita Devnarain, et al.. (2021). Formulation of pH responsive multilamellar vesicles for targeted delivery of hydrophilic antibiotics. Colloids and Surfaces B Biointerfaces. 207. 112043–112043. 14 indexed citations
4.
Hassan, Daniel, et al.. (2021). Hesperidin-loaded nanoemulsions improve cytotoxicity, induce apoptosis, and downregulate miR-21 and miR-155 expression in MCF-7. Journal of Microencapsulation. 38(7-8). 486–495. 16 indexed citations
5.
Hassan, Daniel, Calvin A. Omolo, Victoria Oluwaseun Fasiku, Chunderika Mocktar, & Thirumala Govender. (2020). Novel chitosan-based pH-responsive lipid-polymer hybrid nanovesicles (OLA-LPHVs) for delivery of vancomycin against methicillin-resistant Staphylococcus aureus infections. International Journal of Biological Macromolecules. 147. 385–398. 58 indexed citations
6.
Hassan, Daniel, Calvin A. Omolo, Victoria Oluwaseun Fasiku, et al.. (2020). Formulation of pH-Responsive Quatsomes from Quaternary Bicephalic Surfactants and Cholesterol for Enhanced Delivery of Vancomycin against Methicillin Resistant Staphylococcus aureus. Pharmaceutics. 12(11). 1093–1093. 28 indexed citations
7.
Hassan, Daniel, Calvin A. Omolo, Ramesh Gannimani, et al.. (2019). Delivery of novel vancomycin nanoplexes for combating methicillin resistant Staphylococcus aureus (MRSA) infections. International Journal of Pharmaceutics. 558. 143–156. 37 indexed citations
8.
Singh, Sima, Daniel Hassan, Hibah M. Aldawsari, et al.. (2019). Immune checkpoint inhibitors: a promising anticancer therapy. Drug Discovery Today. 25(1). 223–229. 119 indexed citations
9.
Maji, Ruma, Calvin A. Omolo, Nikhil Agrawal, et al.. (2019). pH-Responsive Lipid–Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens. Molecular Pharmaceutics. 16(11). 4594–4609. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026